#ExpertAnswers: P Boon Lim and Melanie Dani on Autonomic Dysfunction in Long-COVID
Airdate: Thursday, July 22, 2021 Season: 8 Episode: 41
Guests: P. Boon Lim, Melanie Dani
This episode of #ExpertAnswers features Dr. P Boon Lim, Cardiologist and Electrophysiologist, Imperial College London, and Dr. Melanie Dani, Consultant in general and geriatric medicine, Imperial College Healthcare NHS Trust. They joined us for a conversation on the symptoms and diagnostic challenges for patients presenting with autonomic dysfunction in Long-COVID.
For more information or to watch the webinar, click here.
Associated Webinar: Autonomic Dysfunction in Long-COVID
Similar Podcasts
#ExpertAnswers: Artur Federowoski on Cardiovascular Dysautonomia in Post-COVID-19
Artur Federowski explains CV dysautonomia as a specific sequalae of acute COVID-19 and guides the audience in the diagnostic work-up of PASC patients with suspected cardiovascular complications.
#ExpertAnswers: Phil Griffiths on Telemetry Studies
Phil Griffiths draws from his experience as a telemetry user to discuss some important considerations for designing telemetry studies.
#ExpertAnswers: Cole McLarty, Nick Glover, and Tim Hacker on Pressure-Volume Loops
Cole McLarty, Nick Glover and Dr. Timothy Hacker focus on Pressure-Volume Loop collection and data analysis for cardiovascular research.
Related Content
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval Exercise
Dr. Bert Bond and Max Weston will present an overview on their study investigating the effects high-intensity interval exercise has on cerebrovascular health.
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection and Management
Artur Fedorowski, MD, PhD, describes cardiovascular dysautonomia in COVID-19 and the diagnostics behind detecting Long COVID or Post-acute Sequalae of COVID-19.
APS Physiology in Disease Modeling and Drug Development Roundtable
Key opinion leaders in cardiovascular physiology and bioengineering discuss best practices and challenges when modeling cardiomyopathies and other cardiovascular diseases using stem cells, engineered tissues and other novel platforms.